AllergyTalk Episode 22: Could Anti-IL-5 Make Asthma Worse?
Price: FREE for members and non-members
Speaker: Gerald Lee, MD
Viewers can earn credit by completing the post test questions
AllergyTalk is a podcast designed to provide easy access to research summaries from Allergy Watch and recommendations from subject matter experts in order to bring physicians up to date in the latest advances in the field of allergy and immunology.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Primary Care Providers
Fellows-in-Training
Learning Objectives
Upon completion of this activity learners should be able to:
1. Describe the effect of adding a long acting muscarinic antagonist on the small airways of asthmatic smokers on an inhaled corticosteroid.
2. Name a potential mechanism of worsening asthma secondary to anti IL-5 therapy.
3. Compare the efficacy of egg oral immunotherapy compared with baked egg consumption in inducing sustained unresponsiveness to egg.
All identified conflicts of interest have been resolved.
Merin Kalangara (Kuruvilla), MD
Speaker/consultant: GlaxoSmithKline
Gerald Lee, MD
Nothing to disclose
Stanley Fineman, MD
Speaker: Takeda; Research: Aimmune, DBV, Biocryst
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Attendance